Jefferies Group LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 118 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.17 and the average weighting 0.4%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$1,562,919
-13.3%
110,924
+58.8%
0.01%
-13.3%
Q1 2021$1,802,698
-56.4%
69,872
-9.7%
0.02%
-54.5%
Q4 2020$4,136,147
+1609.2%
77,369
+1217.1%
0.03%
+1000.0%
Q3 2020$242,000
-1.6%
5,874
+15.8%
0.00%0.0%
Q2 2020$246,000
+12.3%
5,074
-4.3%
0.00%0.0%
Q1 2020$219,000
-80.2%
5,301
-82.8%
0.00%
-66.7%
Q3 2019$1,108,000
-42.4%
30,780
-66.8%
0.01%
-25.0%
Q3 2018$1,925,000
-73.7%
92,758
-61.9%
0.01%
-64.7%
Q4 2017$7,326,000
-45.2%
243,300
-31.4%
0.03%
-61.8%
Q3 2017$13,368,000
+133.3%
354,900
+72.8%
0.09%
+134.2%
Q2 2017$5,729,000
-70.2%
205,400
-63.2%
0.04%
-73.2%
Q1 2017$19,203,000
+2031.3%
558,567
+1686.8%
0.14%
+2740.0%
Q4 2016$901,000
+5.6%
31,261
+16.5%
0.01%0.0%
Q3 2016$853,000
-20.9%
26,837
-19.3%
0.01%0.0%
Q2 2016$1,079,000
-66.6%
33,240
-71.2%
0.01%
-73.7%
Q1 2016$3,227,000
+252.3%
115,400
+349.0%
0.02%
+280.0%
Q4 2015$916,000
-37.1%
25,700
-41.7%
0.01%
-44.4%
Q3 2015$1,457,000
-7.4%
44,053
+17.2%
0.01%
+12.5%
Q2 2015$1,574,000
+120.8%
37,582
+71.6%
0.01%
+100.0%
Q1 2015$713,000
+72.6%
21,900
+68.5%
0.00%
+100.0%
Q4 2014$413,000
+11.3%
13,000
-13.3%
0.00%
-33.3%
Q3 2014$371,000
-25.5%
15,000
-31.9%
0.00%
-25.0%
Q2 2014$498,000
-8.1%
22,020
-1.1%
0.00%
-20.0%
Q1 2014$542,000
-93.0%
22,258
-92.8%
0.01%
-89.8%
Q4 2013$7,702,000
-0.6%
308,205
+9.2%
0.05%
-35.5%
Q3 2013$7,751,000
+48.5%
282,200
-1.8%
0.08%
+35.7%
Q2 2013$5,219,000287,5040.06%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Sio Capital Management, LLC 563,200$16,243,0009.48%
Avoro Capital Advisors LLC 1,486,460$42,870,0008.66%
Baker Brothers Advisors 25,819,768$744,642,0007.30%
SECTORAL ASSET MANAGEMENT INC 1,176,543$33,932,0003.76%
HARVEY CAPITAL MANAGEMENT INC 251,825$7,262,0003.38%
ACUTA CAPITAL PARTNERS, LLC 300,000$8,652,0003.22%
Palo Alto Investors LP 1,532,030$44,184,0002.52%
Ghost Tree Capital, LLC 350,000$10,094,0002.43%
EMORY UNIVERSITY 76,121$2,195,0002.16%
WEATHERBIE CAPITAL, LLC 576,784$16,634,0002.09%
View complete list of ACADIA PHARMACEUTICALS INC shareholders